Literature DB >> 32114928

Statins and Risk of Intracerebral Hemorrhage in Individuals With a History of Stroke.

Anette Riisgaard Ribe1, Claus Høstrup Vestergaard1, Mogens Vestergaard1,2, Henrik Schou Pedersen1, Anders Prior1, Lone Winther Lietzen3, Peter Krogh Brynningsen3, Morten Fenger-Grøn1,2.   

Abstract

Background and Purpose- It has been suggested that statins increase the risk of intracerebral hemorrhage in individuals with a history of stroke, which has led to a precautionary principle of avoiding statins in patients with prior intracerebral hemorrhage. However, such prescribing reticence may be unfounded and potentially harmful when considering the well-established benefits of statins. This study is so far the largest to explore the statin-associated risk of intracerebral hemorrhage in individuals with prior stroke. Methods- We conducted a population-based, propensity score-matched cohort study using information from Danish national registers. We included all individuals initiating statin treatment after a first-time stroke diagnosis (intracerebral hemorrhage, N=2728 or ischemic stroke, N=52 964) during 2002 to 2016. For up to 10 years of follow-up, they were compared with a 1:5 propensity score-matched group of statin nonusers with the same type of first-time stroke. The difference between groups was measured by adjusted hazard ratios for intracerebral hemorrhage calculated by type of first-time stroke as a function of time since statin initiation. Results- Within the study period, 118 new intracerebral hemorrhages occurred among statin users with prior intracerebral hemorrhage and 319 new intracerebral hemorrhages in users with prior ischemic stroke. The risk of intracerebral hemorrhage was similar for statin users and nonusers when evaluated among those with prior intracerebral hemorrhage, and it was reduced by half in those with prior ischemic stroke. These findings were consistent over time since statin initiation and could not be explained by concomitant initiation of other medications, by dilution of treatment effect (due to changes in exposure status over time), or by healthy initiator bias. Conclusions- This large study found no evidence that statins increase the risk of intracerebral hemorrhage in individuals with prior stroke; perhaps the risk is even lower in the subgroup of individuals with prior ischemic stroke.

Entities:  

Keywords:  cholesterol; epidemiology; propensity score; public health; stroke

Year:  2020        PMID: 32114928     DOI: 10.1161/STROKEAHA.119.027301

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  13 in total

Review 1.  Use of Lipid-Lowering Drugs After Intracerebral Hemorrhage.

Authors:  Ashkan Shoamanesh; Magdy Selim
Journal:  Stroke       Date:  2022-06-06       Impact factor: 10.170

2.  The Validity of Intracerebral Hemorrhage Diagnoses in the Danish Patient Registry and the Danish Stroke Registry.

Authors:  Stine Munk Hald; Christine Kring Sloth; Mikkel Agger; Maria Therese Schelde-Olesen; Miriam Højholt; Mette Hasle; Helle Bogetofte; Ida Olesrud; Stefanie Binzer; Charlotte Madsen; Willy Krone; Luis Alberto García Rodríguez; Rustam Al-Shahi Salman; Jesper Hallas; David Gaist
Journal:  Clin Epidemiol       Date:  2020-12-01       Impact factor: 4.790

3.  Association Between Bipolar Disorder or Schizophrenia and Oral Anticoagulation Use in Danish Adults With Incident or Prevalent Atrial Fibrillation.

Authors:  Morten Fenger-Grøn; Claus Høstrup Vestergaard; Anette Riisgaard Ribe; Søren Paaske Johnsen; Lars Frost; Annelli Sandbæk; Dimitry S Davydow
Journal:  JAMA Netw Open       Date:  2021-05-03

4.  Is the Benefit of Antithrombotics and Statins Worth the Risk of Intracerebral Hemorrhage?: It Depends.

Authors:  Jose Gutierrez
Journal:  J Am Heart Assoc       Date:  2021-02-15       Impact factor: 5.501

5.  Inpatient Management of Acute Stroke of Unknown Type in Resource-Limited Settings.

Authors:  Aaron Berkowitz; Nirali Vora; Morgan L Prust; Deanna Saylor; Stanley Zimba; Fred Stephen Sarfo; Gentle S Shrestha
Journal:  Stroke       Date:  2022-01-20       Impact factor: 7.914

6.  Complex chronic patients as an emergent group with high risk of intracerebral haemorrhage: an observational cohort study.

Authors:  Blanca Lorman-Carbó; Josep Lluís Clua-Espuny; Eulàlia Muria-Subirats; Juan Ballesta-Ors; Maria Antònia González-Henares; José Fernández-Sáez; Francisco M Martín-Luján
Journal:  BMC Geriatr       Date:  2021-02-05       Impact factor: 3.921

7.  Adjunctive Statin Therapy Reduces Mortality After Acute Hemorrhagic Stroke.

Authors:  Chao-Ming Hung; Hao-Kuang Wang; Cheng-Kai Lin; Po-Yuan Chen; Yu-Ying Wu; Cheng-Chun Wu; Han-Jung Chen; Cheng-Loong Liang; Yi-Che Lee; Chi-Wei Lin
Journal:  Risk Manag Healthc Policy       Date:  2021-01-14

Review 8.  Neuroprotective Therapies for Spontaneous Intracerebral Hemorrhage.

Authors:  Kathryn N Kearns; Natasha Ironside; Min S Park; Bradford B Worrall; Andrew M Southerland; Ching-Jen Chen; Dale Ding
Journal:  Neurocrit Care       Date:  2021-08-02       Impact factor: 3.210

9.  Death of a Partner and Risks of Ischemic Stroke and Intracerebral Hemorrhage: A Nationwide Danish Matched Cohort Study.

Authors:  Morten Fenger-Grøn; Ida Paulsen Møller; Henrik Schou Pedersen; Lars Frost; Annelli Sandbæk; Dimitry S Davydow; Søren P Johnsen; Nicklas Vinter
Journal:  J Am Heart Assoc       Date:  2020-11-17       Impact factor: 5.501

10.  Comparison of pleiotropic effects of statins vs fibrates on laboratory parameters in patients with dyslipidemia: A retrospective cohort study.

Authors:  Satoshi Takeuchi; Yasuo Takahashi; Satoshi Asai
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.